Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,757,000 | 6,092,000 | 4,283,000 | 8,166,000 | 4,769,000 |
| Marketable Securities | 60,000 | 78,000 | 83,000 | 87,000 | 86,000 |
| Inventories | 6,216,000 | 5,996,000 | 6,440,000 | 6,396,000 | 5,952,000 |
| Other current assets | 7,491,000 | 7,722,000 | 9,075,000 | 8,329,000 | 11,216,000 |
| TOTAL | $18,524,000 | $20,247,000 | $19,881,000 | $22,978,000 | $22,023,000 |
| Non-Current Assets | |||||
| PPE Net | 10,633,000 | 11,006,000 | 11,205,000 | 11,431,000 | 11,402,000 |
| Intangibles | 39,860,000 | 40,421,000 | 41,552,000 | 42,261,000 | 42,398,000 |
| Other Non-Current Assets | 9,062,000 | 8,757,000 | 8,289,000 | 7,970,000 | 8,559,000 |
| TOTAL | $59,555,000 | $60,184,000 | $61,046,000 | $61,662,000 | $62,359,000 |
| Total Assets | $78,079,000 | $80,431,000 | $80,927,000 | $84,640,000 | $84,382,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,495,000 | N/A | 492,000 | N/A |
| Accounts payable and accrued liabilities | 14,610,000 | 4,357,000 | 15,142,000 | 15,450,000 | 15,310,000 |
| Other current liabilities | 746,000 | 765,000 | 776,000 | 804,000 | 796,000 |
| TOTAL | $20,275,000 | $22,148,000 | $22,179,000 | $23,924,000 | $25,335,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 22,538,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 27,083,000 | 4,208,000 | 27,867,000 | 30,068,000 | 28,044,000 |
| TOTAL | $36,794,000 | $37,475,000 | $38,123,000 | $40,579,000 | $38,950,000 |
| Total Liabilities | $57,069,000 | $59,623,000 | $60,302,000 | $64,503,000 | $64,285,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,346,000 | 1,346,000 | 1,346,000 | 1,346,000 | 1,346,000 |
| Retained earnings | 6,700,000 | 6,755,000 | 7,055,000 | 6,622,000 | 6,353,000 |
| Other shareholders' equity | 3,523,000 | 3,205,000 | 2,605,000 | 2,347,000 | 2,120,000 |
| TOTAL | $14,865,000 | $14,587,000 | $14,286,000 | $13,593,000 | $13,094,000 |
| Total Liabilities And Equity | $71,934,000 | $74,210,000 | $74,588,000 | $78,096,000 | $77,379,000 |